Recombinant IL-6R (Tocilizumab Biosimilar) antibody

Catalog No. ABIN7487791

Product Details anti-IL-6R (Tocilizumab Biosimilar) Antibody

Target: IL-6R (Tocilizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Expression System: Mammalian cells

Clonality: Monoclonal

Conjugate: This IL-6R (Tocilizumab Biosimilar) antibody is un-conjugated

Application: ELISA

Purpose: Tocilizumab Biosimilar - Anti-IL-6R mAb

Characteristics: Antibody Type: IgG1Kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Grade: Research Grade

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: 4 °C,-20 °C

Storage Comment: 4°C for short term, -20°C for long term

Target Details for IL-6R (Tocilizumab Biosimilar)

Target: IL-6R (Tocilizumab Biosimilar)

Abstract: IL-6R (Tocilizumab Biosimilar) Products

Synonyms: CD126 antibody, IL-6R-1 antibody, IL-6RA antibody, IL6Q antibody, IL6RA antibody, IL6RQ antibody, gp80 antibody, interleukin 6 receptor antibody, IL6R antibody

Target Type: Biosimilar

Background: Tocilizumab
Tocilizumab, also known as atlizumab, is a recombinant humanized, anti-human monoclonal antibody (mAb) of the immunoglobulin G1κ subclass directed against soluble and membrane-bound interleukin-6 (IL-6) receptor (IL-6R) which plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer.

CAS-No: 375823-41-9